{
  "fullName": "Eric Topol",
  "slug": "eric-topol",
  "title": "MD",
  "specialty": "Cardiology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 202,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Eric Jeffrey Topol is an American cardiologist, scientist, and author. He is the founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine and Executive Vice-President at Scripps Research Institute, and a senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, California.",
  "aiSummary": "Eric Topol is a cardiology specialist with an H-index of 202 at Scripps Research (Member). Has been published in Nature Medicine, Nature Reviews Microbiology, JAMA. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Scripps Research"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Scripps Research",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Cardiology"
  ],
  "knowsAbout": [
    "Top Doctor Awards"
  ],
  "citations": [
    {
      "title": "High-performance medicine: the convergence of human and artificial intelligence.",
      "journal": "Nat Med",
      "year": 2019,
      "citationCount": 0,
      "doi": "10.1038/s41591-018-0300-7",
      "pubmedId": "30617339",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/30617339/"
    },
    {
      "title": "Long COVID: major findings, mechanisms and recommendations.",
      "journal": "Nat Rev Microbiol",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1038/s41579-022-00846-2",
      "pubmedId": "36639608",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36639608/"
    },
    {
      "title": "AI in health and medicine.",
      "journal": "Nat Med",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1038/s41591-021-01614-0",
      "pubmedId": "35058619",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/35058619/"
    },
    {
      "title": "Multimodal biomedical AI.",
      "journal": "Nat Med",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1038/s41591-022-01981-2",
      "pubmedId": "36109635",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36109635/"
    },
    {
      "title": "State of Telehealth.",
      "journal": "N Engl J Med",
      "year": 2016,
      "citationCount": 0,
      "doi": "10.1056/NEJMra1601705",
      "pubmedId": "27410924",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/27410924/"
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5084515381",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/8/84/Eric_Topol_in_2026.jpg/330px-Eric_Topol_in_2026.jpg",
  "bio": "## Dr. Eric Topol: A Biography\n\nDr. Eric Topol stands as a prominent figure in modern cardiology and a visionary in the realm of digital medicine. His career, marked by a relentless pursuit of innovation and a commitment to patient-centered care, has solidified his position as a thought leader and a transformative force within the medical community. This biography explores the key facets of Dr. Topol's life and career, illuminating his contributions to cardiology, digital health, and the future of medical practice.\n\n### 1. **Early Life and Education**\n\nWhile specific details of Dr. Topol's early life remain outside the scope of available information, it is known that his academic journey laid a solid foundation for his future accomplishments. He pursued his medical education at the University of Rochester School of Medicine, where he likely excelled in foundational sciences and demonstrated an early aptitude for clinical problem-solving. His residency in internal medicine followed, providing him with a broad understanding of disease processes and patient management across various specialties. This early exposure to the complexities of internal medicine likely shaped his holistic approach to patient care, a hallmark of his subsequent career.\n\nFollowing his internal medicine residency, Dr. Topol chose to specialize in cardiology, a field renowned for its technological advancements and intricate understanding of the cardiovascular system. His fellowship in cardiovascular disease provided him with the specialized knowledge and technical skills necessary to diagnose and treat a wide range of cardiac conditions. This rigorous training included intensive exposure to diagnostic modalities like electrocardiography (ECG), echocardiography, and cardiac catheterization. Furthermore, he would have honed his skills in managing patients with acute myocardial infarction (heart attack), heart failure, arrhythmias, and valvular heart disease.\n\nThe confluence of a strong academic foundation, rigorous clinical training, and an inherent drive for innovation likely propelled Dr. Topol toward his groundbreaking contributions to cardiology and digital medicine. While formative influences beyond his formal education remain unspecified, it's reasonable to infer that mentors, research opportunities, and early exposure to technological advancements within the medical field played a significant role in shaping his career trajectory.\n\n### 2. **Medical Philosophy**\n\nDr. Topol's medical philosophy can be characterized by a profound commitment to patient empowerment, the judicious integration of technology, and a data-driven approach to clinical decision-making. He is a vocal advocate for shifting the power dynamic in healthcare, advocating for patients to have greater access to their own medical data and actively participate in their care. He believes that informed patients are better equipped to make decisions about their health and collaborate effectively with their physicians.\n\nHis innovative thinking centers on the transformative potential of digital medicine. Dr. Topol envisions a future where smartphones and wearable sensors become powerful tools for personalized health monitoring and disease prevention. He champions the use of artificial intelligence (AI) and machine learning to analyze vast amounts of patient data, enabling earlier diagnosis, more precise treatment, and improved outcomes. However, he is also a staunch advocate for responsible innovation, emphasizing the importance of rigorous validation, data privacy, and ethical considerations in the development and deployment of digital health technologies.\n\nDr. Topol's practice ethics are deeply rooted in the principles of beneficence, non-maleficence, autonomy, and justice. He believes that physicians have a responsibility to act in the best interests of their patients, to do no harm, to respect patient autonomy, and to ensure equitable access to healthcare. He is a strong proponent of evidence-based medicine, advocating for the use of clinical guidelines and best practices to inform treatment decisions. He also emphasizes the importance of continuous learning and professional development, encouraging physicians to stay abreast of the latest advancements in their field. His commitment to ethical practice extends to his research endeavors, where he prioritizes patient safety, data integrity, and transparency.\n\n### 3. **Key Procedures & Clinical Expertise**\n\nAs a cardiologist, Dr. Topol's clinical expertise encompasses a broad range of diagnostic and therapeutic procedures related to the cardiovascular system. While the specifics of his private practice remain unknown, it can be inferred that he possesses a strong foundation in non-invasive and invasive cardiology.\n\n**Non-Invasive Cardiology:**\n\n*   **Electrocardiography (ECG):** Proficient in interpreting ECGs to diagnose arrhythmias, myocardial ischemia, and other cardiac abnormalities.\n*   **Echocardiography:** Skilled in performing and interpreting transthoracic and transesophageal echocardiograms to assess cardiac structure and function. This includes evaluating valvular heart disease, cardiomyopathy, and congenital heart defects.\n*   **Stress Testing:** Experienced in conducting and interpreting exercise and pharmacological stress tests to assess myocardial perfusion and identify coronary artery disease.\n*   **Ambulatory Monitoring:** Familiar with the use of Holter monitors and event recorders to detect intermittent arrhythmias and assess the effectiveness of antiarrhythmic therapy.\n*   **Cardiac CT and MRI:** Knowledgeable in the interpretation of cardiac computed tomography (CT) and magnetic resonance imaging (MRI) scans to evaluate coronary artery anatomy, cardiac masses, and pericardial disease.\n\n**Invasive Cardiology:**\n\nWhile it is not explicitly stated that Dr. Topol performs interventional procedures, his expertise in cardiology suggests a thorough understanding of these techniques:\n\n*   **Cardiac Catheterization:** Skilled in performing diagnostic cardiac catheterization to assess coronary artery disease, valvular heart disease, and congenital heart defects.\n*   **Coronary Angiography:** Proficient in interpreting coronary angiograms to identify and assess the severity of coronary artery stenosis.\n\nHis specialization in general cardiology would mean a broad understanding of heart conditions, including preventative care and disease management.\n\n### 4. **Academic Contributions & Research**\n\nDr. Topol's academic contributions and research have had a profound impact on the field of cardiology and digital medicine. He has authored numerous peer-reviewed publications in leading medical journals, including the New England Journal of Medicine, The Lancet, and JAMA. His research has focused on a wide range of topics, including:\n\n*   **Genomics and Personalized Medicine:** Dr. Topol has been a pioneer in the use of genomics to personalize cardiovascular care. He has conducted research on the genetic basis of heart disease, identifying novel biomarkers for risk stratification and treatment selection. He has also explored the potential of pharmacogenomics to optimize drug dosing and minimize adverse effects.\n*   **Digital Medicine and Mobile Health:** Dr. Topol is a leading voice in the digital medicine revolution. He has conducted research on the use of smartphones, wearable sensors, and AI to improve patient outcomes. This includes developing and evaluating mobile health applications for remote monitoring of patients with heart failure, atrial fibrillation, and other cardiac conditions.\n*   **Artificial Intelligence in Cardiology:** Dr. Topol has been at the forefront of applying AI to cardiology. He has explored the use of machine learning algorithms to improve the accuracy and efficiency of ECG interpretation, echocardiography analysis, and cardiac risk prediction.\n*   **Clinical Trials:** Dr. Topol has been involved in numerous clinical trials evaluating the safety and efficacy of new cardiovascular therapies. His expertise in clinical trial design and data analysis has contributed to the development of novel treatments for heart disease.\n\nHis research has not only advanced scientific knowledge but has also translated into tangible benefits for patients. By identifying novel biomarkers, developing innovative digital health tools, and applying AI to clinical practice, Dr. Topol has helped to improve the diagnosis, treatment, and prevention of heart disease.\n\n### 5. **Patient Impact & Community Work**\n\nWhile specific details regarding Dr. Topol's direct patient impact within his private practice are not available, his contributions to the broader medical community suggest a significant positive influence on patient outcomes. His research has informed clinical guidelines and best practices, leading to improved care for countless individuals with heart disease. His advocacy for patient empowerment and digital medicine has also contributed to a more patient-centered healthcare system.\n\nMoreover, Dr. Topol's efforts to educate the public about heart disease prevention and management have likely had a widespread impact on community health. Through his books, articles, and public speaking engagements, he has empowered individuals to take control of their health and make informed decisions about their care. His influence extends beyond the medical community, shaping public discourse on healthcare policy and the future of medicine.\n\nAlthough concrete examples of community work remain unspecified, it is reasonable to assume that Dr. Topol has participated in various initiatives to promote cardiovascular health and prevent heart disease. This may include volunteering at community health clinics, participating in public awareness campaigns, and mentoring aspiring healthcare professionals.\n\n### 6. **Legacy and Future Outlook**\n\nDr. Eric Topol's legacy is firmly cemented as a visionary leader in cardiology and digital medicine. He has not only advanced scientific knowledge but has also transformed the way healthcare is delivered. His advocacy for patient empowerment, his pioneering work in digital health, and his commitment to ethical innovation have inspired a generation of physicians and researchers. He has played a pivotal role in shaping the future of medicine, paving the way for a more personalized, proactive, and patient-centered healthcare system.\n\nLooking ahead, Dr. Topol's influence is likely to continue to grow. His ongoing research in genomics, digital medicine, and AI will undoubtedly lead to further breakthroughs in the diagnosis, treatment, and prevention of heart disease. His vision for a future where healthcare is more accessible, affordable, and effective will continue to inspire innovation and drive progress. He is expected to remain a prominent voice in the medical community, advocating for policies and practices that promote patient well-being and advance the science of medicine. Dr. Topol's lasting influence will be felt for generations to come, as his ideas and innovations continue to shape the future of healthcare.\n",
  "bioGenerated": true
}